Home NDC 60505-4533 Lenalidomide
Product NDC 60505-4533
11-digit product format 605054533
Labeler code 60505
Product ID 60505-4533_0ac7ca79-cd31-4bc1-ddc6-a90c9efcc1c4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lenalidomide
Dosage form CAPSULE
Route ORAL
Labeler Apotex Corp.
Application ANDA211022
Marketing category ANDA
Marketing start 2022-09-06
Substance LENALIDOMIDE
Active strength 5 mg/1
Pharmacologic classes Thalidomide Analog [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211022-001 LENALIDOMIDE LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 A211022-002 LENALIDOMIDE LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 A211022-003 LENALIDOMIDE LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 A211022-004 LENALIDOMIDE LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 A211022-005 LENALIDOMIDE LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2023-03-07 A211022-006 LENALIDOMIDE LENALIDOMIDE 20MG CAPSULE / ORAL AB 2023-03-07
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 154 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A211022-001 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211022-002 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211022-003 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211022-004 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211022-005 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2023-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211022-006 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2023-03-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211022-001 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211022-002 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211022-003 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211022-004 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211022-005 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2023-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211022-006 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2023-03-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A211022-001 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211022-002 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211022-003 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211022-004 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211022-005 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2023-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211022-006 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2023-03-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211022-001 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211022-002 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211022-003 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211022-004 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211022-005 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2023-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211022-006 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2023-03-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211022-001 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211022-002 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211022-003 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211022-004 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211022-005 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2023-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211022-006 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2023-03-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211022-001 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211022-002 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211022-003 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211022-004 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211022-005 LENALIDOMIDE 2.5MG CAPSULE / ORAL AB 2023-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211022-006 LENALIDOMIDE 20MG CAPSULE / ORAL AB 2023-03-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211022-001 LENALIDOMIDE 5MG CAPSULE / ORAL AB 2022-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211022-002 LENALIDOMIDE 10MG CAPSULE / ORAL AB 2022-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211022-003 LENALIDOMIDE 15MG CAPSULE / ORAL AB 2022-08-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211022-004 LENALIDOMIDE 25MG CAPSULE / ORAL AB 2022-08-30 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 154 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Lenalidomide
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LENALIDOMIDE 5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination F0P408N6V4 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 6 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 602910 Internal RxNorm lookup 602912 Internal RxNorm lookup 643712 Internal RxNorm lookup 643720 Internal RxNorm lookup 1242231 Internal RxNorm lookup 1428947 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60505-4533-1 Lenalidomide 100 in 1 BOTTLE CAPSULE 100 6 60505-4533-2 Lenalidomide 28 in 1 BOTTLE CAPSULE 28 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60505-4533 LENALIDOMIDE CAPSULE [APOTEX CORP.] 5 Current NDC, Legacy NDC, 2 package rows 20240704_9943e098-20b0-dbb3-af12-7816eedd3f70.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 60505-4533-1 60505453301 100 CAPSULE in 1 BOTTLE (60505-4533-1) 100 capsule 2022-09-06 0000-00-00 No No Current 60505-4533-2 60505453302 28 CAPSULE in 1 BOTTLE (60505-4533-2) 28 capsule 2022-09-06 0000-00-00 No No Current